Drugs that contain Fenofibrate

1. List of Antara (micronized) drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8026281 LUPIN Treating metabolic syndrome with fenofibrate
Apr, 2025

(2 years from now)

US9314447 LUPIN Reduced dose pharmaceutical compositions of fenofibrate
May, 2033

(10 years from now)

Market Authorisation Date: 30 November, 2004

Treatment: Treating severe hypertriglyceridemia; Treating primary hypercholesterolemia and mixed dyslipidemia

Dosage: CAPSULE;ORAL

How can I launch a generic of ANTARA (MICRONIZED) before it's patent expiration?
More Information on Dosage

2. List of Fenoglide drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8124125 SALIX Solid dosage form comprising a fibrate
Oct, 2024

(1 year, 7 months from now)

US8481078 SALIX Solid dosage form comprising a fibrate
Oct, 2024

(1 year, 7 months from now)

US9173847 SALIX Tablet comprising a fibrate
Oct, 2024

(1 year, 7 months from now)

US7658944 SALIX Solid dosage form comprising a fibrate
Dec, 2024

(1 year, 10 months from now)

Market Authorisation Date: 10 August, 2007

Treatment: For reducing total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides, and treating hypertriglyceridemia; Use of fenofibrate for reducing elevated total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides

Dosage: TABLET;ORAL

How can I launch a generic of FENOGLIDE before it's patent expiration?
More Information on Dosage

3. List of Tricor drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7320802 ABBVIE Methods of treatment using nanoparticulate fenofibrate compositions
Feb, 2023

(20 days from now)

US7276249 ABBVIE Nanoparticulate fibrate formulations
Feb, 2023

(20 days from now)

Market Authorisation Date: 05 November, 2004

Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hypertriglyceridemia (types iv, v)

Dosage: TABLET;ORAL

How can I launch a generic of TRICOR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in